GlaxoSmithKline Pharmaceuticals Limited GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline Pharmaceuticals Limited

GLAXO

Kedudukan dalam Saham #3780
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Harga Saham
$25.73
Modal Pasaran
$4.36B
Perubahan (1 hari)
-5.33%
Perubahan (1 tahun)
-17.92%
Negara
IN
Perdagangan GlaxoSmithKline Pharmaceuticals Limited (GLAXO)

Kategori

Healthcare
Sejarah harga saham bagi GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Harga penutupan tertinggi: $28.33 pada 2026-10-01

Harga penutupan terendah: $7.46 pada 1999-01-01
Sejarah harga saham GlaxoSmithKline Pharmaceuticals Limited dari 1999 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) -0.80%
2025 3.53%
2024 30.13%
2023 28.84%
2022 -31.26%
2021 11.05%
2020 -8.11%
2019 15.01%
2018 5.68%
2017 -5.61%
2016 -18.58%
2015 0.11%
2014 11.37%
2013 16.93%
2012 5.11%
2011 -25.99%
2010 39.42%
2009 47.96%
2008 -8.92%
2007 -0.02%
2006 7.37%
2005 41.03%
2004 38.71%
2003 85.99%
2002 3.08%
2001 -33.62%
2000 -42.61%
1999 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$1.27K 56.64%
US
$257.61 33.52%
US
$284.48 24.40%
US
$149.84 71.03%
US
$480.80 30.43%
CH